Trials / Completed
CompletedNCT06860620
Efficacy of Zinc Supplementation in Maintaining Sustained Remission in Children With Steroid-sensitive Nephrotic Syndrome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 192 (actual)
- Sponsor
- Muhammad Aamir Latif · Academic / Other
- Sex
- All
- Age
- 2 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to fill the gaps by determining the efficacy of zinc supplementation in maintaining sustained remission in children with steroid sensitive nephrotic syndrome (SSNS).
Detailed description
There is a need to ascertain the efficacy of zinc supplementation in maintaining sustained remission in children with SSNS, thereby lowering the number of relapses and disease morbidity. The findings of this study could pave the way for reasonable evidence about the role of zinc supplementation is sustained remission in children with SSNS.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Zinc supplementation plus standard treatment | children were given 5 mg of elemental zinc sulfate as a single daily dose for children less than 4 years of age and 10 mg for children more than 4 years of age for a total duration of 6 months, along with standard therapy. |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
- First posted
- 2025-03-06
- Last updated
- 2025-03-06
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT06860620. Inclusion in this directory is not an endorsement.